Agastiya Biotech
Agastiya Biotech
  • Media
  • Careers
  • Contact
  • Home
  • Pipeline
  • Technology
    • AB001: Gene Silencing Immunotherapy
    • ABREV001: pan-Mutated KRAS
  • Clinical Trials
  • About
Select Page

stacey-lawson2

Dec 21, 2017

stacey-lawson2

Recent Posts

  • Vopec Pharmaceuticals and Agastiya Biotech Announce Breakthrough Phase 1 Study Results of Small Molecule AB001 for Multiple Metastatic Solid Tumors
  • Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML)
  • Introducing Quantum Medicine to the World
  • Agastiya Biotech Proceeding with Drug Candidate for COVID-19: Small Molecule Compound for Treatment of SARS-CoV-2
  • Vopec gets NOC & test license from DCGI to develop new cancer drug that offers therapeutic option for COVID-19

Recent Comments

    Archives

    • April 2024
    • May 2022
    • January 2022
    • April 2020
    • March 2020
    • February 2020
    • July 2019
    • December 2018

    Categories

    • Media

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Agastiya Biotech 

    • Home
    • Pipeline
    • Research
    • Clinical Trials
    • Presentations & Publications
    • About

    © 2026 All Rights Reserved